Julian Symons
Chief Tech/Sci/R&D Officer bij ALIGOS THERAPEUTICS, INC.
Vermogen: 390 123 $ op 29-02-2024
Profiel
Presently, Julian A.
Symons holds the position of Chief Scientific Officer & Executive VP at Aligos Therapeutics, Inc.
In the past he held the position of Vice President-Disease Area Research & Development at Alios BioPharma, Inc.
He received an undergraduate degree from the University of Central Lancashire and a doctorate from York University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 394 064 ( 0.52% ) | 390 123 $ | 29-02-2024 |
Actieve functies van Julian Symons
Bedrijven | Functie | Begin |
---|---|---|
ALIGOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-05-2018 |
Eerdere bekende functies van Julian Symons
Bedrijven | Functie | Einde |
---|---|---|
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01-04-2018 |
Opleiding van Julian Symons
York University | Doctorate Degree |
University of Central Lancashire | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALIGOS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Health Technology |